HB 667
(113th Regular Session (2023-2024))
Drugs, Prescription - As introduced, makes various changes to the prescription drug donation repository program operated by the department of health. - Amends TCA Title 56; Title 63 and Title 68.
|
Jan 26 2023 |
H. Placed On Regular Calendar For 4/6/2023
Mar 30 2023
|
SB 675
(113th Regular Session (2023-2024))
Drugs, Prescription - As introduced, makes various changes to the prescription drug donation repository program operated by the department of health. - Amends TCA Title 56; Title 63 and Title 68.
|
Jan 26 2023 |
H. Placed On Regular Calendar For 4/6/2023
Mar 30 2023
|
SB 1314
(113th Regular Session (2023-2024))
Drugs, Prescription - As introduced, prohibits a healthcare prescriber from issuing a prescription for a dual-purpose prescription medication for diabetes to a person in this state if the person does not have a diagnosis of diabetes; defines a dual-purpose prescription medication for diabetes as a prescription drug that has a listed indication for diabetes and may also be used for purposes of weight loss in persons who do not have a diagnosis of diabetes. - Amends TCA Title 53; Title 56; Title 63; Title 68 and Title 71.
|
Jan 31 2023 |
Assigned To S/C Health Subcommittee
Feb 07 2023
|
HB 1419
(113th Regular Session (2023-2024))
Drugs, Prescription - As introduced, prohibits a healthcare prescriber from issuing a prescription for a dual-purpose prescription medication for diabetes to a person in this state if the person does not have a diagnosis of diabetes; defines a dual-purpose prescription medication for diabetes as a prescription drug that has a listed indication for diabetes and may also be used for purposes of weight loss in persons who do not have a diagnosis of diabetes. - Amends TCA Title 53; Title 56; Title 63; Title 68 and Title 71.
|
Jan 31 2023 |
Assigned To S/C Health Subcommittee
Feb 07 2023
|
HB 266
(113th Regular Session (2023-2024))
Drugs, Prescription - As introduced, removes the "within 10 days after January 1, 2015" factor from the requirement that each medical practitioner, unless the practitioner meets an exception, must ensure that the undispensed inventory of opioids and benzodiazepines purchased under the prescriber's drug enforcement administration number for dispensing is returned to a licensed third party reverse distributor or turned into local law enforcement. - Amends TCA Title 4; Title 9; Title 20; Title 33; Title 38; Title 39; Title 47; Title 49; Title 53; Title 63; Title 68 and Title 71.
|
Jan 19 2023 |
Passed On Second Consideration, Refer To Senate Judiciary Committee
Feb 02 2023
|
SB 691
(113th Regular Session (2023-2024))
Drugs, Prescription - As introduced, removes the "within 10 days after January 1, 2015" factor from the requirement that each medical practitioner, unless the practitioner meets an exception, must ensure that the undispensed inventory of opioids and benzodiazepines purchased under the prescriber's drug enforcement administration number for dispensing is returned to a licensed third party reverse distributor or turned into local law enforcement. - Amends TCA Title 4; Title 9; Title 20; Title 33; Title 38; Title 39; Title 47; Title 49; Title 53; Title 63; Title 68 and Title 71.
|
Jan 19 2023 |
Passed On Second Consideration, Refer To Senate Judiciary Committee
Feb 02 2023
|
SB 2465
(112th Regular Session (2021-2022))
Drugs, Prescription - As enacted, requires a healthcare prescriber to offer a prescription for an opioid antagonist, or another drug approved for complete or partial reversal of an opioid overdose event, to each patient prescribed an opioid, if certain conditions are present; authorizes imposition of civil penalty against a person who violates the requirement to offer such a drug; provides exception for opioid prescriptions to palliative care patients. - Amends TCA Title 53 and Title 63.
|
Jan 31 2022 |
Pub. Ch. 1061
Jun 01 2022
|
HB 2228
(112th Regular Session (2021-2022))
Drugs, Prescription - As enacted, requires a healthcare prescriber to offer a prescription for an opioid antagonist, or another drug approved for complete or partial reversal of an opioid overdose event, to each patient prescribed an opioid, if certain conditions are present; authorizes imposition of civil penalty against a person who violates the requirement to offer such a drug; provides exception for opioid prescriptions to palliative care patients. - Amends TCA Title 53 and Title 63.
|
Jan 31 2022 |
Comp. Became Pub. Ch. 1061
Jun 01 2022
|
HB 2746
(112th Regular Session (2021-2022))
Drugs, Prescription - As enacted, authorizes a pharmacist to provide ivermectin to a patient, who is 18 years of age or older, pursuant to a valid collaborative pharmacy practice agreement containing a non-patient-specific prescriptive order and standardized procedures developed and executed by one or more authorized prescribers; enacts other related provisions. - Amends TCA Title 4; Title 14; Title 47; Title 53; Title 63; Title 68 and Title 71.
|
Jan 31 2022 |
Pub. Ch. 908
Apr 26 2022
|
SB 2188
(112th Regular Session (2021-2022))
Drugs, Prescription - As enacted, authorizes a pharmacist to provide ivermectin to a patient, who is 18 years of age or older, pursuant to a valid collaborative pharmacy practice agreement containing a non-patient-specific prescriptive order and standardized procedures developed and executed by one or more authorized prescribers; enacts other related provisions. - Amends TCA Title 4; Title 14; Title 47; Title 53; Title 63; Title 68 and Title 71.
|
Jan 31 2022 |
Comp. Became Pub. Ch. 908
Apr 26 2022
|
SB 1390
(112th Regular Session (2021-2022))
Drugs, Synthetic or Analogue - As introduced, adds as requirements for sale of Kratom that sales only be made by retailers and sold only in packaging of five ounces to seven ounces; violation is a Class A misdemeanor. - Amends TCA Title 39, Chapter 17, Part 4.
|
Feb 11 2021 |
Failed In S/C Criminal Justice Subcommittee Of Criminal Justice Committee
Mar 30 2022
|
HB 1493
(112th Regular Session (2021-2022))
Drugs, Synthetic or Analogue - As introduced, adds as requirements for sale of Kratom that sales only be made by retailers and sold only in packaging of five ounces to seven ounces; violation is a Class A misdemeanor. - Amends TCA Title 39, Chapter 17, Part 4.
|
Feb 11 2021 |
Placed On Senate Judiciary Committee Calendar For 3/30/2022
Mar 30 2022
|
SB 2037
(112th Regular Session (2021-2022))
Drugs, Prescription - As introduced, requires a practitioner to discuss with a patient the risks associated with a Schedule II controlled, dangerous substance or other opioid pain reliever prior to the initial prescription and prior to the third prescription. - Amends TCA Title 39; Title 40; Title 53; Title 63 and Title 68.
|
Jan 27 2022 |
Failed In S/C Health Subcommittee Of Health Committee
Mar 22 2022
|
HB 2259
(112th Regular Session (2021-2022))
Drugs, Prescription - As introduced, requires a practitioner to discuss with a patient the risks associated with a Schedule II controlled, dangerous substance or other opioid pain reliever prior to the initial prescription and prior to the third prescription. - Amends TCA Title 39; Title 40; Title 53; Title 63 and Title 68.
|
Jan 27 2022 |
Failed In S/C Health Subcommittee Of Health Committee
Mar 22 2022
|
SB 522
(112th Regular Session (2021-2022))
Drugs, Prescription - As introduced, caps the total amount that a health insurance carrier can require a covered patient with diabetes to pay for a 30-day supply of insulin at no more than $100; caps the total price that a person who supplies prescription insulin drugs into or within this state for use by a patient with diabetes can charge for a 30-day supply of insulin at no more than $100. - Amends TCA Title 8; Title 53; Title 56, Chapter 7; Title 63 and Title 71, Chapter 5.
|
Feb 01 2021 |
No Action Taken
Mar 15 2022
|
HB 451
(112th Regular Session (2021-2022))
Drugs, Prescription - As introduced, caps the total amount that a health insurance carrier can require a covered patient with diabetes to pay for a 30-day supply of insulin at no more than $100; caps the total price that a person who supplies prescription insulin drugs into or within this state for use by a patient with diabetes can charge for a 30-day supply of insulin at no more than $100. - Amends TCA Title 8; Title 53; Title 56, Chapter 7; Title 63 and Title 71, Chapter 5.
|
Feb 01 2021 |
No Action Taken
Mar 15 2022
|
SB 1444
(112th Regular Session (2021-2022))
Drugs, Prescription - As introduced, removes an expired rulemaking deadline for the board for licensing health care facilities to promulgate rules related to disposal of controlled substances and other prescription drugs. - Amends TCA Title 4; Title 53; Title 68 and Title 71.
|
Feb 11 2021 |
Assigned To General Subcommittee Of Senate Health And Welfare Committee
Mar 09 2022
|
HB 1262
(112th Regular Session (2021-2022))
Drugs, Prescription - As introduced, removes an expired rulemaking deadline for the board for licensing health care facilities to promulgate rules related to disposal of controlled substances and other prescription drugs. - Amends TCA Title 4; Title 53; Title 68 and Title 71.
|
Feb 11 2021 |
Assigned To General Subcommittee Of Senate Health And Welfare Committee
Mar 09 2022
|
SB 2207
(112th Regular Session (2021-2022))
Drugs, Prescription - As introduced, removes provision requiring the comptroller of the treasury to study by January 1, 2005, the use of prescription drugs in nursing homes and the costs of those prescription drugs for residents of nursing homes. - Amends TCA Title 4; Title 33; Title 53; Title 56; Title 63; Title 68 and Title 71.
|
Jan 31 2022 |
Action Deferred In Senate Commerce And Labor Committee To 3/15/2022
Mar 08 2022
|
HB 2527
(112th Regular Session (2021-2022))
Drugs, Prescription - As introduced, removes provision requiring the comptroller of the treasury to study by January 1, 2005, the use of prescription drugs in nursing homes and the costs of those prescription drugs for residents of nursing homes. - Amends TCA Title 4; Title 33; Title 53; Title 56; Title 63; Title 68 and Title 71.
|
Jan 31 2022 |
Action Deferred In Senate Commerce And Labor Committee To 3/15/2022
Mar 08 2022
|
